A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Efficacy and Safety of Nefecon in Patients with Primary IgA Nephropathy at Risk of Progressing to End-Stage Renal Disease (NefIgArd)

  • Mohamed, Amr Ahmed (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date1/14/19 → 8/31/21